Strategic R&D associates with foreign research institutes on the rise.

Published: 2004-03-15 07:00:00

Updated: 2004-03-15 07:00:00

Since the implementation of the product patent system, the domestic drug industry strived to secure pipeline products by means of a technology licensing but largely went failure due to too competition among rival companies. To overcome this hurdle many local drug industries are trying to explore ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK